PMC:7441788 / 37079-37247 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T147","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A147","pred":"mondo_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"nts receiving HCQ treatment had minor adverse effects (headache and rash) [50]. Prolonged QT interval after taking HCQ may also develop in ICU COVID-19 patients [67]. A"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T271","span":{"begin":167,"end":168},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"nts receiving HCQ treatment had minor adverse effects (headache and rash) [50]. Prolonged QT interval after taking HCQ may also develop in ICU COVID-19 patients [67]. A"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T134","span":{"begin":143,"end":151},"obj":"Species"}],"attributes":[{"id":"A134","pred":"ncbi_taxonomy_id","subj":"T134","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"nts receiving HCQ treatment had minor adverse effects (headache and rash) [50]. Prolonged QT interval after taking HCQ may also develop in ICU COVID-19 patients [67]. A"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T255","span":{"begin":80,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nts receiving HCQ treatment had minor adverse effects (headache and rash) [50]. Prolonged QT interval after taking HCQ may also develop in ICU COVID-19 patients [67]. A"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1345","span":{"begin":152,"end":160},"obj":"Species"},{"id":"1369","span":{"begin":14,"end":17},"obj":"Chemical"},{"id":"1370","span":{"begin":115,"end":118},"obj":"Chemical"},{"id":"1408","span":{"begin":55,"end":63},"obj":"Disease"},{"id":"1409","span":{"begin":68,"end":72},"obj":"Disease"},{"id":"1410","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A1345","pred":"pubann:denotes","subj":"1345","obj":"Tax:9606"},{"id":"A1369","pred":"pubann:denotes","subj":"1369","obj":"MESH:D006886"},{"id":"A1370","pred":"pubann:denotes","subj":"1370","obj":"MESH:D006886"},{"id":"A1408","pred":"pubann:denotes","subj":"1408","obj":"MESH:D006261"},{"id":"A1409","pred":"pubann:denotes","subj":"1409","obj":"MESH:D005076"},{"id":"A1410","pred":"pubann:denotes","subj":"1410","obj":"MESH:C000657245"}],"text":"nts receiving HCQ treatment had minor adverse effects (headache and rash) [50]. Prolonged QT interval after taking HCQ may also develop in ICU COVID-19 patients [67]. A"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T139","span":{"begin":68,"end":72},"obj":"Disease"},{"id":"T140","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A139","pred":"mondo_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/MONDO_0006547"},{"id":"A140","pred":"mondo_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"nts receiving HCQ treatment had minor adverse effects (headache and rash) [50]. Prolonged QT interval after taking HCQ may also develop in ICU COVID-19 patients [67]. A"}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T33","span":{"begin":55,"end":63},"obj":"Phenotype"},{"id":"T34","span":{"begin":68,"end":72},"obj":"Phenotype"},{"id":"T35","span":{"begin":80,"end":101},"obj":"Phenotype"}],"attributes":[{"id":"A33","pred":"hp_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/HP_0002315"},{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0000988"},{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0001657"}],"text":"nts receiving HCQ treatment had minor adverse effects (headache and rash) [50]. Prolonged QT interval after taking HCQ may also develop in ICU COVID-19 patients [67]. A"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1345","span":{"begin":152,"end":160},"obj":"Species"},{"id":"1369","span":{"begin":14,"end":17},"obj":"Chemical"},{"id":"1370","span":{"begin":115,"end":118},"obj":"Chemical"},{"id":"1408","span":{"begin":55,"end":63},"obj":"Disease"},{"id":"1409","span":{"begin":68,"end":72},"obj":"Disease"},{"id":"1410","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A1345","pred":"tao:has_database_id","subj":"1345","obj":"Tax:9606"},{"id":"A1369","pred":"tao:has_database_id","subj":"1369","obj":"MESH:D006886"},{"id":"A1370","pred":"tao:has_database_id","subj":"1370","obj":"MESH:D006886"},{"id":"A1408","pred":"tao:has_database_id","subj":"1408","obj":"MESH:D006261"},{"id":"A1409","pred":"tao:has_database_id","subj":"1409","obj":"MESH:D005076"},{"id":"A1410","pred":"tao:has_database_id","subj":"1410","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nts receiving HCQ treatment had minor adverse effects (headache and rash) [50]. Prolonged QT interval after taking HCQ may also develop in ICU COVID-19 patients [67]. A"}

{"project":"LitCovid-sentences","denotations":[{"id":"T255","span":{"begin":80,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nts receiving HCQ treatment had minor adverse effects (headache and rash) [50]. Prolonged QT interval after taking HCQ may also develop in ICU COVID-19 patients [67]. A"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T34","span":{"begin":55,"end":63},"obj":"Phenotype"},{"id":"T35","span":{"begin":68,"end":72},"obj":"Phenotype"},{"id":"T36","span":{"begin":80,"end":101},"obj":"Phenotype"}],"attributes":[{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0002315"},{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0000988"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0001657"}],"text":"nts receiving HCQ treatment had minor adverse effects (headache and rash) [50]. Prolonged QT interval after taking HCQ may also develop in ICU COVID-19 patients [67]. A"}